Dale and Appelbe’s Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive reference work on this subject in the UK.
Sales and UpgradesContent Updates
Commentary on the latest standards and guidance from the General Pharmaceutical Council
Content covering all human medicines legislation including controlled drugs, with animal medicines also included
Information consolidating the law on poisons, denatured alcohols and chemicals
Complete coverage of the pharmacy undergraduate and pre-registration syllabus and British law relating to medicines and poisons
Publication Updates
11 Oct
Dale and Appelbe’s Pharmacy and Medicines Law October 2022 Update
This update contains:
• Revised and restructured new edition of a highly successful text
• New chapters: introduction to the law, criminal and civil liability, medical devices, lawfully conducting a retail pharmacy business, confidentiality, data protection, and more
• Greater prominence to professional regulation and NHS chapters
• Over 50 additional cases than in previous editions to illustrate application of law
10 Mar
Dale and Appelbe’s Pharmacy and Medicines Law March 2018 update
Chapters 17 and 18 have now been revised and updated
08 Aug
Dale and Appelbe’s Pharmacy and Medicines Law: New Edition
New Edition of Dale and Appelbe’s Pharmacy and Medicines Law now available
The eleventh edition has been fully revised in line with current law and regulation. Chapters 2–16 now cover all human medicines legislation, including controlled drugs. Chapter 17 covers legislation on animal medicines and a new chapter 18 consolidates the law on poisons, denatured alcohols and chemicals.
Chapters on controlled drugs and the section on poisons have been completely rewritten to make them more accessible. Information on the Falsified Medicines Directive and pharmacovigilance has been added to all relevant chapters, as has commentary on the latest standards and guidance from the General Pharmaceutical Council. The chapter on fitness to practise contains new case law and revised procedural protocols.